tetano
Editor, Senior Moderator
Medicina (B Aires). 2014;74(3):245-53.
[Influenza and pneumococcal immunization in cardiovascular prevention].
[Article in Spanish]
Sosa Liprandi MI1, Sosa Liprandi A, Fern?ndez A, Stecher D, Bonveh? P, Ver?n MT.
Author information
Abstract
A group of interdisciplinary experts (cardiologists, clinicians, infectologists met with the purpose of analyzing the evidence revealed by the relationship between respiratory diseases caused by influenza, pneumococcal diseases and cardiovascular events, and the role played by immunization strategies applied in cardiovascular prevention. The present statement summarizes the conclusions reached by the expertise of the aforementioned professionals. Systematic revisions imply consistent evidence that influenza and pneumococcal infection lead to acute myocardial infarction and cardiovascular death. Studies published during the last 15 years suggest that vaccination against influenza and S. pneumoniae reduce the risk of acute coronary syndromes. With the current evidence, and considering cost-effectiveness, reducing operating expenses and safety profile of the vaccines, scientific societies, national and international government health agencies strongly recommend incorporating immunization programs in those patients with chronic cardiovascular disease.
KEYWORDS:
acute myocardial infarction; cardiovascular prevention; influenza; pneumococcal pneumonia; vaccines
PMID:
24918678
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/24918678
[Influenza and pneumococcal immunization in cardiovascular prevention].
[Article in Spanish]
Sosa Liprandi MI1, Sosa Liprandi A, Fern?ndez A, Stecher D, Bonveh? P, Ver?n MT.
Author information
Abstract
A group of interdisciplinary experts (cardiologists, clinicians, infectologists met with the purpose of analyzing the evidence revealed by the relationship between respiratory diseases caused by influenza, pneumococcal diseases and cardiovascular events, and the role played by immunization strategies applied in cardiovascular prevention. The present statement summarizes the conclusions reached by the expertise of the aforementioned professionals. Systematic revisions imply consistent evidence that influenza and pneumococcal infection lead to acute myocardial infarction and cardiovascular death. Studies published during the last 15 years suggest that vaccination against influenza and S. pneumoniae reduce the risk of acute coronary syndromes. With the current evidence, and considering cost-effectiveness, reducing operating expenses and safety profile of the vaccines, scientific societies, national and international government health agencies strongly recommend incorporating immunization programs in those patients with chronic cardiovascular disease.
KEYWORDS:
acute myocardial infarction; cardiovascular prevention; influenza; pneumococcal pneumonia; vaccines
PMID:
24918678
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/24918678